IW-3300

N/A

Report date: 2025/03/01 20:00:43
NME

Base Information

Drug NameIW-3300
Drug Alias NameIW-3300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNatriuretic peptide receptor 3 agonistsGuanylate cyclase stimulants
TargetsNatriuretic peptide receptor 3Guanylate cyclase
Therapy Area/IndicationsEndometriosisCystitis, Interstitial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIronwood Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesIronwood Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsEndometriosisCystitis, Interstitial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A